Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 3NET 1Gastrointestinal 1CNS 1

Conditions

Neuroendocrine Tumors 12Carcinoid Tumor 7Somatostatinoma 4Neoplasms 4Insulinoma 4Glucagonoma 4Gastro-enteropancreatic neuroendocrine tumor 4Carcinoma, Islet Cell 4Vipoma 3Gastrinoma 3Adenoma, Islet Cell 3Acromegaly 3Pituitary Neoplasms 2Neoplasm Metastasis 2Carcinoma, Medullary 2Carcinoma 2Zollinger-Ellison Syndrome 1Serotonin Syndrome 1Pheochromocytoma 1Paraganglioma 1Pancreatic Neuroendocrine Tumor G2 1Neoplastic Cells, Circulating 1Malignant Carcinoid Syndrome 1Head and Neck Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

pasireotide 5lanreotide 3Octreotide 3Cabergoline 2pegvisomant 1Transcranial Magnetic Stimulation 1Tissue Banks 1Surgical Procedures, Operative 1Solutions 1Radiosurgery 1Observation 1Magnetic Resonance Spectroscopy 1Injections 1Dosage Forms 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Acromegaly × Octreotide × Endocrine × Clear all
NCT05364944 2025-11-17

OXTEND-01

Debiopharm International SA

Phase 1 Terminated
19 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed
20 enrolled
CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT01029275 2014-07-31

SAPORO

University Hospital, Rouen

Phase NA Completed
89 enrolled
Endocrine

Acromegaly, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡